On Nov. 14, 2025, Merck and Cidara Therapeutics, a biotechnology company developing drug-Fc conjugate (DFC) therapeutics, announced that…
On Nov. 13, 2025, the World Health Organization (WHO) reported that Health authorities in Ethiopia are carrying out…
On Nov. 13, 2025, the U.S. Food and Drug Administration (FDA) approved multiple denosumab biosimilars, enhancing market access…
On Nov. 11, 2025, Pfizer and Metsera announced the companies have entered into a definitive agreement under which…
On Nov. 11, 2025, the United Kingdom government announced that animal testing in science is set to be…
On Nov. 11, 2025, China introduced a visa that will allow young foreign researchers in science, technology, engineering…
On Nov. 10, 2025, a study led by the University of Liverpool reported that existing evidence does not…
On Nov. 6, 2025, the Institute for Health Metrics and Evaluation (IHME) at the University of Washington School…
On Nov. 6, 2025, the World Health Organization (WHO) released a technical report, The future of paediatric clinical trials…
On Nov. 6, 2025, Eli Lilly announced an agreement with the U.S. government to expand access to its…
On Nov. 6, 2025, scientists from Oxford’s Radcliffe Department of Medicine have achieved the most detailed view yet…
On Nov. 6, 2025, Novo Nordisk announced it has agreed with the U.S. Administration to lower drug prices…
On Nov. 4, 2025, the U.S. Food and Drug Administration (FDA) approved revumenib, a first-in-class oral menin inhibitor,…
On Oct. 30, 2025, the California Institute for Regenerative Medicine (CIRM) approved awarding $27 million through three grants…
On Oct. 29, 2025, Thermo Fisher announced it would buy privately held data management company Clario for up…
On Oct. 29, 2025, University of North Carolina at Charlotte (UNC) researchers leading a multidisciplinary team across four…
On Oct. 29, 2025, Rice University announced the creation of the Rice Brain Institute (RBI), an ambitious, interdisciplinary…
On Oct. 28, 2025, Eli Lilly said on Tuesday it was collaborating with Nvidia to build a supercomputer…
On Oct. 27, 2025, researchers from Johns Hopkins Medicine and the Johns Hopkins Bloomberg School of Public Health…
On Oct. 26, 2025, Novartis announced that it has entered into an agreement to acquire Avidity Biosciences, a…
On Oct. 24, 2025, Eli Lilly and Adverum Biotechnologies announced a definitive agreement for Lilly to acquire Adverum,…
On Oct. 22, 2025, Alkermes and Avadel Pharmaceuticals announced the companies have entered into a definitive agreement under…
On Oct. 22, 2025, the South Carolina Department of Public Health (SCDPH) announced it is actively responding to…
On Oct. 22, 2025, a Roslin Institute led team announced they have developed pigs that are resistant to…
On Oct. 20, 2025, Merck announced the start of construction for a $3 billion, 400,000-square-foot pharmaceutical manufacturing facility…
On Oct. 20, 2025, Glaukos announced today the U.S. Food and Drug Administration (FDA) approved its Epioxa™ HD…
On Oct. 20, 2025, The Jackson Laboratory (JAX), a global leader in genetics and genomic medicine, announced it…
On Oct. 20, 2025, ACG, the world’s most integrated provider of solid-dosage solutions, announced a $200 million phased…
On Oct. 18, 2025, the Swiss Pharma giant F Hoffmann La Roche (Roche) suffered a setback as the…
On Oct. 17, 2025, Chinese biotech Hansoh Pharma said it had signed a license agreement worth up to…